Xeris Biopharma Holdings, Inc. XERS Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s change in inventories?
- Xeris Biopharma Holdings, Inc. (XERS) reported change in inventories of -$851K in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s change in inventories changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s change in inventories decreased by 123.5% year-over-year, from $3.62M to -$851K.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s change in inventories?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s change in inventories has grown at a 27.0% compound annual growth rate (CAGR), from $7.42M to $19.29M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.